Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Fan, Ying ^a   Wei, Chengguo ^b   Xiao, Wenzhen ^a   Zhang, Weijia ^b   Wang, Niansong ^a   Chuang, Peter Y ^b   He, John Cijiang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CXCL11 CHEMOKINE; FATTY ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RETINOID; SPON1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXA1 GENE; ARTICLE; CCL2 GENE; CCL5 GENE; CONTROLLED STUDY; CXCL11 GENE; DISEASE COURSE; DOWN REGULATION; FATTY ACID METABOLISM; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY BIOPSY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINOID METABOLISM; SPON1 GENE; TRANSGENIC MOUSE; UBD GENE; UPREGULATION; VALIDATION STUDY;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HIV-1; KIDNEY CORTEX; KIDNEY DISEASES; MICE; MICE, TRANSGENIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 84899866266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093019     Document Type: Article

References (20)

1. Appel LJ, Wright JT, Jr., Greene T, Kusek JW, Lewis JB, et al. (2008) Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med 168: 832-839. (Pubitemid 351620085)
2. Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, et al. (2011) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. Cochrane Database Syst Rev: CD007751.
3. Martini S, Eichinger F, Nair V, Kretzler M (2008) Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord 9: 267-274.
4. Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, et al. (2009) Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58: 469-477.
5. Hodgin JB, Borczuk AC, Nasr SH, Markowitz GS, Nair V, et al. (2010) A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol 177: 1674-1686.
6. Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, et al. (2009) Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 174: 2073-2085.
7. Bhavnani SK, Eichinger F, Martini S, Saxman P, Jagadish HV, et al. (2009) Network analysis of genes regulated in renal diseases: implications for a molecular-based classification. BMC Bioinformatics 10 Suppl 9: S3.
8. Brosius FC, 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, et al. (2009) Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512.
9. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, et al. (1991) HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119.
10. Lu TC, He JC, Klotman P (2006) Animal models of HIV-associated nephropathy. Curr Opin Nephrol Hypertens 15: 233-237.
11. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, et al. (1992) Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 89: 1577-1581.
12. Ratnam KK, Feng X, Chuang PY, Verma V, Lu TC, et al. Role of the retinoic acid receptor-alpha in HIV-associated nephropathy. Kidney Int 79: 624-634.
13. Wang H, Liu H, Jia Z, Olsen C, Litwin S, et al. (2010) Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice. Am J Physiol Renal Physiol 298: F754-762.
14. Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294: F697-701.
15. Krensky AM, Ahn YT (2007) Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol 3: 164-170. (Pubitemid 46327139)
16. Gong P, Canaan A, Wang B, Leventhal J, Snyder A, et al. (2009) The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol 21: 316-326.
17. Araujo LP, Truzzi RR, Mendes GE, Luz MA, Burdmann EA, et al. (2010) Interaction of the anti-inflammatory annexin A1 protein and tacrolimus immunosuppressant in the renal function of rats. Am J Nephrol 31: 527-533.
18. Clemitson JR, Dixon RJ, Haines S, Bingham AJ, Patel BR, et al. (2007) Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene. Circ Res 100: 992-999. (Pubitemid 46598923)
19. Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, et al. (2011) Transcriptome analysis of human diabetic kidney disease. Diabetes 60: 2354-2369.
20. Bar-Joseph Z (2004) Analyzing time series gene expression data. Bioinformatics 20: 2493-2503.